Pharyngocutaneous fistulas (PCF) are a common postoperative complication following head and neck surgery, particularly after total laryngectomy. These types of fistulas represent a challenge for both patients and clinicians due to their persistence and resistance to conventional healing methods. Hyperbaric Oxygen Therapy (HBOT) has been proposed as an adjunctive treatment to enhance healing and closure of PCF. While many studies report positive outcomes, the results are not universally consistent. This comprehensive review aimed to examine the clinical evidence supporting the efficacy of HBOT in the management of pharyngocutaneous fistulas, focusing on fistula closure rates, infection control, and overall healing improvement. All publications without the restriction of time and published in the English language were included. Searches were performed in the PubMed, MEDLINE, Scopus, and Embase databases. Ten articles were included in this review. The evaluation of our clinical experience with this method of treating PCF showed results comparable to those found in the literature and analyzed among the studies reviewed. Several studies indicate that HBOT promotes fistula closure, reduces healing time, and enhances the local immune response, but further investigation is required to optimize protocols and patients’ selections
Hyperbaric Oxygen Therapy for Pharyngocutaneous Fistula Following Head and Neck Surgery: A Comprehensive Review and Our Clinical Experience
Christian Barbato
;
2025
Abstract
Pharyngocutaneous fistulas (PCF) are a common postoperative complication following head and neck surgery, particularly after total laryngectomy. These types of fistulas represent a challenge for both patients and clinicians due to their persistence and resistance to conventional healing methods. Hyperbaric Oxygen Therapy (HBOT) has been proposed as an adjunctive treatment to enhance healing and closure of PCF. While many studies report positive outcomes, the results are not universally consistent. This comprehensive review aimed to examine the clinical evidence supporting the efficacy of HBOT in the management of pharyngocutaneous fistulas, focusing on fistula closure rates, infection control, and overall healing improvement. All publications without the restriction of time and published in the English language were included. Searches were performed in the PubMed, MEDLINE, Scopus, and Embase databases. Ten articles were included in this review. The evaluation of our clinical experience with this method of treating PCF showed results comparable to those found in the literature and analyzed among the studies reviewed. Several studies indicate that HBOT promotes fistula closure, reduces healing time, and enhances the local immune response, but further investigation is required to optimize protocols and patients’ selections| File | Dimensione | Formato | |
|---|---|---|---|
|
oxygen-05-00003 (5).pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
346.22 kB
Formato
Adobe PDF
|
346.22 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


